Veterinary Poc Hematology Diagnostics Market Expected to Reach $2.3 Billion by 2030

According to a new report published by Allied Market Research, titled, “Veterinary Poc Hematology Diagnostics Market," The veterinary poc hematology diagnostics market size was valued at $1.3 billion in 2024, and is estimated to reach $2.3 billion by 2030, growing at a CAGR of 9.3% from 2025 to 2030.

Veterinary PoC hematology diagnostics enable rapid blood analysis for animals, allowing veterinarians to make timely clinical decisions. These diagnostic tools are crucial in detecting anemia, infections, inflammatory conditions, and blood disorders in various species. Portable hematology analyzers provide immediate results, reducing the need for external laboratory testing and streamlining treatment plans. Technological advancements, such as automated cell counting and species-specific calibration, have improved the accuracy and efficiency of these devices.

According to veterinary Poc hematology diagnostics market analysis major factors driving the growth of the veterinary PoC hematology diagnostics market size  include rise in demand for livestock health monitoring, convenience and faster results, expanding veterinary clinics and mobile veterinary services, regulatory support and awareness programs, and increase in adoption of companion animal insurance. Farmers and livestock producers are increasingly adopting real-time diagnostic solutions to detect and manage diseases early, ensuring optimal herd health and productivity.

Rise in zoonotic diseases, stringent regulations on animal health, and the economic impact of disease outbreaks have further emphasized the need for rapid, on-site testing. PoC hematology diagnostics enable quick and accurate blood analysis, allowing veterinarians to make timely treatment decisions without relying on centralized laboratories.

According to veterinary Poc hematology diagnostics market trends analysis rise in adoption of companion animal insurance is driving the growth of the veterinary Poc hematology diagnostics market by improving pet owners' ability to afford advanced diagnostic services. According to the North American Pet Health Insurance Association, the total number of pets insured in the U.S. by end of 2023, was nearly 6.25 million. As more pet owners seek comprehensive health coverage for their animals, insurance plans often cover diagnostic tests, including hematology screenings, facilitating early disease detection and routine monitoring.

This growing financial accessibility encourages veterinary clinics to invest in PoC hematology analyzers, which offer rapid and reliable results, enabling timely clinical decisions. In addition, expansion of pet insurance providers and inclusion of preventive care in coverage plans further support the demand for PoC hematology diagnostics, as veterinarians are more likely to recommend these tests when cost is less of a barrier for pet owners. Thus, the rise in adoption of companion animal insurance is expected to drive the veterinary Poc hematology diagnostics market growth.

The Veterinary Poc Hematology Diagnostics Industry is segmented on the basis of product type, application, animal type, end user, and region. On the basis of product type, the market is divided into instruments and consumables. The instruments segment is further divided into hematology analyzers, blood gas and electrolyte analyzers, coagulation analyzers, and others.

On the basis of application, the market is divided into blood disorders, metabolic disorders, and other conditions. On the basis of animal type, the veterinary Poc hematology diagnostics industry is divided into livestock animals, companion animals, and others. The livestock animals segment is further classified into cattle, swine, poultry, and others. The companion animals segment is further divided into dogs, horse, cat, and others.

On the basis of end user, the market is segregated into veterinary clinics, veterinary hospitals, research laboratories, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

On the basis of product type, the consumables segment was the major revenue contributor in 2024, owing to continuous demand for reagents, test kits, and other disposable supplies essential for routine diagnostic procedures. Rise in prevalence of infectious diseases and blood disorders in companion and livestock animals has driven the need for frequent hematology testing, ensuring a continuous demand for consumables.

However, the instruments segment is expected to register the highest CAGR during the forecast period, owing to increase in adoption of advanced diagnostic devices that offer rapid, accurate, and real-time blood analysis. Technological advancements, such as integration of artificial intelligence and cloud-based connectivity in diagnostic instruments, have enhanced their efficiency and ease of use, making them more appealing to veterinarians.

On the basis of application, the blood disorders segment was the dominated Veterinary Poc Hematology Diagnostics Market Share 2024. This is attributed to rise in prevalence of hematological conditions in companion and livestock animals, including anemia, thrombocytopenia, and leukopenia. Increased pet ownership and rise in awareness among veterinarians and pet owners regarding early disease detection have fueled demand for rapid and accurate point-of-care diagnostics.

However, according to veterinary Poc hematology diagnostics market forecast analysis the metabolic disorders segment is expected to register the highest CAGR during the forecast period, owing to rise in incidence of conditions such as diabetes mellitus, ketosis, and hypocalcemia in companion and livestock animals. Rise in pet obesity rates and changing dietary patterns have led to surge in metabolic disorders among dogs and cats, necessitating early detection and continuous monitoring through rapid point-of-care diagnostics.

On the basis of animal type, the livestock animals segment was the major revenue contributor in 2024. This is attributed to rise in number of live stocks animal, rise in prevalence of infectious diseases, metabolic disorders, and parasitic infections in cattle, sheep, and pigs, and growing concerns about food safety and stringent regulations regarding livestock health management, which have encouraged farmers and veterinarians to adopt PoC diagnostics for efficient herd monitoring.

However, according to veterinary Poc hematology diagnostics market opportunity analysis the companion animals segment is expected to register the highest CAGR during the forecast period, owing to rise in pet population and increase in adoption of pet insurance.

On the basis of end user, the veterinary clinics segment was the highest revenue contributor in 2024. This is attributed to increasing pet ownership and rise in expenditure on companion animal healthcare. Pet owners are increasingly seeking immediate and accurate diagnostic solutions for their animals, driving the demand for point-ofcare (PoC) hematology diagnostics in veterinary clinics.

However, the veterinary hospitals segment is expected to register the highest CAGR during the forecast period, owing to rise in demand for advanced diagnostic solutions and specialized veterinary care. Veterinary hospitals are equipped with state-of-the-art diagnostic facilities, allowing them to handle complex and critical cases that require rapid and precise hematology testing. The rising prevalence of chronic and infectious diseases in animals, coupled with growing emphasis on early disease detection, is driving the adoption of PoC hematology diagnostics in these settings.

On the basis of region, North America accounted for a majority of the veterinary Poc hematology diagnostics market share in 2024 and is anticipated to remain dominant during the forecast period. This is attributed to well-established veterinary healthcare infrastructure, high pet ownership rates, and significant spending on animal health. The increasing prevalence of zoonotic diseases and chronic conditions in companion and livestock animals has driven the demand for point-of-care diagnostic solutions that enable rapid and accurate blood analysis. In addition, the presence of key market players, such as IDEXX Laboratories and Zoetis, has contributed to the widespread availability and adoption of advanced hematology diagnostic devices.

However, Asia-Pacific is anticipated to witness the fastest growth during the forecast period, owing to increase in awareness regarding animal health, and the growing prevalence of zoonotic diseases. The expanding livestock population, driven by rise in demand for animal derived food products, further boosts the need for effective diagnostic solutions. In addition, improvements in veterinary healthcare infrastructure, coupled with increase in government initiatives to promote animal welfare, contribute to the veterinary Poc hematology diagnostics market growth.

Key Findings of The Study

• By product type, the consumables segment was the highest contributor to the market in 2024. However, instruments segment is expected to register highest CAGR in forecast period.
• By application, the blood disorders segment was the highest contributor to the market in 2024. However, metabolic disorders segment is expected to register highest CAGR in forecast period.
• By animal type, the livestock animals segment was the highest contributor to the market in 2024. However, the companion animals segment is expected to register highest CAGR in forecast period.
• By end user, the veterinary clinics segment dominated the market in 2024, However, the veterinary hospitals segment is expected to register highest CAGR in forecast period.
• By region, North America garnered the largest revenue share in 2024. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period.